Board MeetingJun 23, 2026, 07:31 AM
Plus Therapeutics to Host Business Update Call on June 30
AI Summary
Plus Therapeutics, Inc. announced it will host a business update conference call and webcast on June 30, 2026, at 8:30 a.m. ET. Management will provide updates on the CNSide® diagnostic launch, the integrated development plan for its lead drug Reyobiq, and its CNS oncology strategy. The call will also cover the company's native artificial intelligence development plans, with the CEO expressing excitement about progress across all three areas.
Key Highlights
- Plus Therapeutics to host a business update conference call.
- Call scheduled for Tuesday, June 30, 2026, at 8:30 a.m. Eastern Time.
- Management will discuss CNSide® diagnostic launch.
- Update on integrated development plan for lead drug Reyobiq.
- Details on CNS oncology strategy and AI development plans.
- CEO highlights substantial progress in diagnostics, therapeutics, and AI.
Price Impact
More from PSTV